M281

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for M281, covering 2021-10-27 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia [Phase 2, Phase 3]